Literature DB >> 1825504

The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

E Egea1, A Iglesias, M Salazar, C Morimoto, M S Kruskall, Z Awdeh, S F Schlossman, C A Alper, E J Yunis.   

Abstract

We had previously obtained evidence that among normal subjects the humoral antibody response to hepatitis B surface antigen (HBsAg) was bimodally distributed with about 14% of subjects producing less than 1,000 estimated radioimmunoassay RIA units. From the study of major histocompatibility complex (MHC) markers in the very poor responders who produced less than 36 estimated RIA units of antibody, it appeared that there was an excess of homozygotes for two extended haplotypes [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7]. This finding suggested that a poor response was inherited as a recessive trait requiring nonresponse genes for HBsAg on both MHC haplotypes and was strengthened by finding a much lower antibody response among prospectively immunized homozygotes for [HLA-B8, SC01, DR3] compared with heterozygotes. In the present study, we have analyzed the cellular basis for nonresponse to this antigen by examining antigen-specific proliferation of T cells from responders and nonresponders in the presence and absence of autologous CD8+ (suppressor) cells. Peripheral blood cells from nonresponders to HBsAg failed to undergo a proliferative response to recombinant HBsAg in vitro, whereas cells from responders proliferated vigorously. This failure of cells from nonresponders to proliferate was not reversed in cell mixtures containing CD4+ and antigen-presenting cells devoid of CD8+ cells. There was no difference between responders and nonresponders with respect to the number of circulating T cells or their subsets, or the proliferative response to mitogens such as pokeweed or phytohemagglutinin or another antigen, tetanus toxoid. Our results indicate that our HBsAg nonresponding subjects have a very specific failure in antigen presentation or the stimulation of T helper cells, or both. Our evidence is against specific immune suppression as the basis for their nonresponsiveness. The failure of antigen presentation or T cell help is consistent with recessive inheritance of nonresponsiveness and suggests that response is dominantly inherited.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825504      PMCID: PMC2118833          DOI: 10.1084/jem.173.3.531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Immunogenetic analysis of the immune response to hepatitis B virus antigens.

Authors:  D R Milich
Journal:  Immunol Ser       Date:  1989

2.  Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells.

Authors:  H Watanabe; S Matsushita; N Kamikawaji; K Hirayama; M Okumura; T Sasazuki
Journal:  Hum Immunol       Date:  1988-05       Impact factor: 2.850

3.  Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.

Authors:  T Sone; K Tsukamoto; K Hirayama; Y Nishimura; T Takenouchi; M Aizawa; T Sasazuki
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

4.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  Alterations in the immune response of nonresponders to the hepatitis B vaccine.

Authors:  M J Nowicki; M J Tong; R E Bohman
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

6.  An HLA-linked gene controls susceptibility to lepromatous leprosy through T cell regulation.

Authors:  I Kikuchi; T Ozawa; K Hirayama; T Sasazuki
Journal:  Lepr Rev       Date:  1986-12       Impact factor: 0.537

7.  Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

Authors:  D E Craven; Z L Awdeh; L M Kunches; E J Yunis; J L Dienstag; B G Werner; B F Polk; D R Syndman; R Platt; C S Crumpacker
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

8.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

9.  HLA-linked nonresponsiveness to Cryptomeria japonica pollen antigen. I. Nonresponsiveness is mediated by antigen-specific suppressor T cell.

Authors:  S Matsushita; M Muto; M Suemura; Y Saito; T Sasazuki
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

10.  The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs.

Authors:  I Green; W E Paul; B Benacerraf
Journal:  J Exp Med       Date:  1966-05-01       Impact factor: 14.307

View more
  29 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine.

Authors:  Maria Bolther; Karen Lise Dahl Andersen; Martin Tolstrup; Kumar Visvanathan; Ian Woolley; Narelle Skinner; Rosemary Millen; Nadia Warner; Lars Østergaard; Søren Jensen-Fangel
Journal:  Hum Vaccin Immunother       Date:  2018-04-11       Impact factor: 3.452

5.  Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.

Authors:  M Salazar; H Deulofeut; C Granja; R Deulofeut; D E Yunis; D Marcus-Bagley; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 6.  Hepatitis B vaccine by intradermal route in non responder patients: an update.

Authors:  Martina Filippelli; Elena Lionetti; Alessia Gennaro; Angela Lanzafame; Teresa Arrigo; Carmelo Salpietro; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 7.  Overview of vaccines.

Authors:  G Ada
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

Review 8.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

9.  Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.

Authors:  C Fayolle; D O'Callaghan; P Martineau; A Charbit; J M Clément; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Anuradha Ganesan; Amy C Weintrob; Nancy F Crum-Cianflone; R Vincent Barthel; Robert J O'Connell; Ann Fieberg; Helen M Chun; Vincent C Marconi; Matthew J Dolan; Brian K Agan
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.